Edition:
India

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

13.00USD
1:30am IST
Change (% chg)

$-0.93 (-6.68%)
Prev Close
$13.93
Open
$13.73
Day's High
$13.73
Day's Low
$13.00
Volume
1,622
Avg. Vol
3,657
52-wk High
$18.91
52-wk Low
$12.01

Crane, Rosemary 

Ms. Rosemary A. Crane has been Independent Vice Chairman of the Board at Zealand Pharma A/S since April 21, 2015. Ms. Rosemary Crane has been CEO of Mela Sciences (2013-2014) and Epocrates (2008-2011), besides having held a number of senior positions in Johnson & Johnson and BMS. She is Member of the Board of Teva Pharmaceutical Industries Ltd. and Edge Therapeutics. Rose has a BA in Communication from the State University of New York, MBA from Kent State University.

Basic Compensation

Total Annual Compensation, DKK 400,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 400,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alf Nicklasson

650,000

Britt Meelby Jensen

11,078,000

Rosemary Crane

400,000

Mats Blom

6,405,000

Ivan Moeller

--

Andrew Parker

--
As Of  31 Dec 2017